CSL New Zealand Biostate Human Coagulation Factor VIII, Freeze-Dried 500IU, powder for injection Australia - engelsk - Department of Health (Therapeutic Goods Administration)

csl new zealand biostate human coagulation factor viii, freeze-dried 500iu, powder for injection

csl behring australia pty ltd - factor viii,von willebrand factor -

CSL New Zealand Biostate Human Coagulation Factor VIII, Freeze-Dried 250IU, powder for injection Australia - engelsk - Department of Health (Therapeutic Goods Administration)

csl new zealand biostate human coagulation factor viii, freeze-dried 250iu, powder for injection

csl behring australia pty ltd - factor viii,von willebrand factor -

CSL New Zealand Biostate Human Coagulation Factor VIII, Freeze Dried 1000IU, powder for injection Australia - engelsk - Department of Health (Therapeutic Goods Administration)

csl new zealand biostate human coagulation factor viii, freeze dried 1000iu, powder for injection

csl behring australia pty ltd - factor viii,von willebrand factor -

CSL New Zealand Biostate Human Coagulation Factor VIII, Freeze Dried 500IU (100IU/mL), powder for injection Australia - engelsk - Department of Health (Therapeutic Goods Administration)

csl new zealand biostate human coagulation factor viii, freeze dried 500iu (100iu/ml), powder for injection

csl behring australia pty ltd - factor viii,von willebrand factor -

CSL New Zealand Biostate Human Coagulation Factor VIII, Freeze-Dried 500 IU, powder for injection Australia - engelsk - Department of Health (Therapeutic Goods Administration)

csl new zealand biostate human coagulation factor viii, freeze-dried 500 iu, powder for injection

csl behring australia pty ltd - factor viii, quantity: 500 iu; von willebrand factor, quantity: 1000 iu - injection, diluent for - excipient ingredients: water for injections - biostate is indicated for - the treatment and prophylaxis of haemorrhage or surgical bleeding in vwd when desmopressin (ddavp) treatment alone is ineffective or contraindicated - the treatment and prophylaxis of bleeding associated with factor viii deficiency due to haemophilia a.

CSL New Zealand Biostate Human Coagulation Factor VIII, Freeze Dried 500 IU (100IU/mL), powder for injection Australia - engelsk - Department of Health (Therapeutic Goods Administration)

csl new zealand biostate human coagulation factor viii, freeze dried 500 iu (100iu/ml), powder for injection

csl behring australia pty ltd - factor viii, quantity: 500 iu; von willebrand factor, quantity: 1000 iu - injection, diluent for - excipient ingredients: water for injections - biostate is indicated for - the treatment and prophylaxis of haemorrhage or surgical bleeding in vwd when desmopressin (ddavp) treatment alone is ineffective or contraindicated - the treatment and prophylaxis of bleeding associated with factor viii deficiency due to haemophilia a.

CSL New Zealand Biostate Human Coagulation Factor VIII, Freeze-Dried 250 IU, powder for injection Australia - engelsk - Department of Health (Therapeutic Goods Administration)

csl new zealand biostate human coagulation factor viii, freeze-dried 250 iu, powder for injection

csl behring australia pty ltd - factor viii, quantity: 250 iu; von willebrand factor, quantity: 500 iu - injection, diluent for - excipient ingredients: water for injections - biostate is indicated for: - the treatment and prophylaxis of haemorrhageor surgical bleeding in vwd when desmopressin (ddavp) treatmentalone is ineffective or contraindicated - the treatment and prophylaxis ofbleeding associated with factor viii deficiency due to haemophilia a.

DRIED FACTOR VIII FRACTION B.P. HEAT TREATED Irland - engelsk - HPRA (Health Products Regulatory Authority)

dried factor viii fraction b.p. heat treated

aventis behring limited - factor viii (antihaemophilic factor) - 250 international unit

HEMOFIL M ANTIHEMOPHILLIC FACTOR (HUMAN) METHOD M MONOCLONAL PURIFIED Israel - engelsk - Ministry of Health

hemofil m antihemophillic factor (human) method m monoclonal purified

takeda israel ltd - factor viii (human) - powder for solution for injection - factor viii (human) 220 - 2000 iu/vial - coagulation factor viii - coagulation factor viii - hemophilia a - for the prevention and control of hemorrhagic episodes

KOATE DVI 500 Israel - engelsk - Ministry of Health

koate dvi 500

padagis israel agencies ltd, israel - factor viii (human) - powder for solution for injection - factor viii (human) 500 iu/vial - coagulation factor viii - coagulation factor viii - for the treatment of classical hemophilia (hemophilia a) in which there is a demonstrated deficiency of activity of the plasma clotting factor, factor viii . koate-dvi provides a means of temporarily replacing the missing clotting factor in order to control or prevent bleeding episodes, or in order to perform emergency and elective surgery on individuals with hemophilia.